Sponsors (3)
The bill would likely expand life-saving, cost‑effective maternal and child health interventions in partner countries and improve transparency and coordination — but requires new U.S. spending, adds administrative burdens, and risks crowding out other health needs or excluding some vulnerable populations.
Pregnant women and children in targeted partner countries will get expanded access to prenatal multiple micronutrient supplements (MMS) and other prioritized maternal-and-child-health (MCH) services, likely reducing maternal anemia, child malnutrition, and preventable maternal and infant deaths.
Children in priority countries will gain wider access to vaccines and treatments for diarrhea and pneumonia, reducing child infectious-disease mortality and morbidity.
U.S. investment in cost‑effective interventions (like immunization and prioritized MCH services) promises high returns per dollar, making foreign health assistance more economically efficient.
U.S. taxpayers face higher federal spending to expand overseas MMS and MCH programs (authorizations up to $150M/year), creating budgetary trade‑offs or the need for offsets elsewhere in the federal budget.
Prioritizing MMS and narrowly defined, cost‑effective interventions risks crowding out other essential maternal and child health services (e.g., skilled birth attendance, obstetric care, context‑specific programs) that are critical but harder to measure.
Projected mortality and health gains may not materialize if trial-based MMS effectiveness does not translate in real-world settings or if partner-country health systems lack capacity to meet coverage targets.
Based on analysis of 6 sections of legislative text.
Directs U.S. foreign assistance to prioritize maternal and child survival, scale prenatal MMS and other life‑saving interventions, require a 5‑year strategy and annual country‑level reporting, and authorizes up to $150M/year for MMS activities (FY2026–FY2030).
Official title: To provide support for scaling up global access to multiple micronutrient supplements and other cost effective maternal and child interventions, and for other purposes.
Introduced July 2, 2026 by Young Kim · Last progress July 2, 2026
Directs the primary U.S. foreign assistance agency to make maternal and child survival a central U.S. global health priority and to scale high-impact, cost‑effective interventions—especially multiple micronutrient supplements (MMS) for pregnant women—in selected partner countries. It requires a 5‑year maternal and child health strategy, annual country-level reporting, priority‑country selections for MMS scale‑up, and authorizes funding to support program implementation and reporting over FY2026–FY2030. Sets measurable targets for 2030 (reduce preventable child and maternal mortality to a specified share of deaths and reach at least 70% coverage of a target set of life‑saving interventions in 10–15 priority countries), requires standardized performance indicators and budget coding across agencies, and authorizes up to $150 million per year for five fiscal years for the State Department Global Health Programs Account to carry out the MMS priority-country activities.